0001987607-23-000002.txt : 20231117 0001987607-23-000002.hdr.sgml : 20231117 20231117134508 ACCESSION NUMBER: 0001987607-23-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20231117 DATE AS OF CHANGE: 20231117 EFFECTIVENESS DATE: 20231117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENIE Therapeutics, Inc. CENTRAL INDEX KEY: 0001987607 IRS NUMBER: 844343969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-488093 FILM NUMBER: 231417597 BUSINESS ADDRESS: STREET 1: 1207 DELAWARE AVENUE #1118 CITY: WILMINGTON STATE: DE ZIP: 19806 BUSINESS PHONE: 3364166787 MAIL ADDRESS: STREET 1: 1207 DELAWARE AVENUE #1118 CITY: WILMINGTON STATE: DE ZIP: 19806 D/A 1 primary_doc.xml X0708 D/A LIVE 0001987607 GENIE Therapeutics, Inc. 1207 DELAWARE AVENUE #1118 WILMINGTON DE DELAWARE 19806 3364166787 DELAWARE Gene Facelift, LLC None Corporation true 2019 Aaron Tabor 1207 Delaware Avenue #1118 Wilmington DE DELAWARE 19806 Executive Officer Biotechnology Decline to Disclose 06c true 0001987607-23-000001 true false true false 5000 Indefinite 0 Indefinite Sales made prior to the date of the filing of this Form D/A were made pursuant to 506(b), and sales made subsequent to the filing of this Form D/A will be made pursuant to 506(c). false 0 0 0 0 false GENIE Therapeutics, Inc. Aaron Tabor Aaron Tabor Chief Executive Officer 2023-11-17